Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Interesting

Interesting

posted on Oct 30, 2009 08:35AM

Eclat will launch a market validation study.........

Eclat recently assisted the Company with an assessment of key management, and has also been working with the Company to identify strategic options for the Company's wholly owned subsidiary..........

Patriot's Board engaged Eclat's team of experienced business consultants to help assess the strategic direction of PDSG and to assist in identifying the optimum operational structure and focus of PDSG.........

Eclat is assisting the Company in its search for a Chief Executive Officer with targeted industry experience able to take the company to the next level of growth and revenue. The market validation study will be an essential tool in framing the competencies sought for the CEO candidate.........

It looks like Eclat is running the company (PDSG) and would appear Flowers is definatly temporary in appointment.......How long for this new study (completion before the SHM?) and who's been the catylist on calling these shots?........

Share
New Message
Please login to post a reply